New booster shot for teens aims to strengthen protection against three serious diseases

NCT ID NCT07596173

Not yet recruiting ⭐️ VACCINE ⭐️ Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

First seen May 30, 2026 · Last updated May 30, 2026

Summary

This study tests a booster vaccine that protects against diphtheria, tetanus, and whooping cough in healthy Japanese adolescents aged 11 to 13. About 85 participants will receive one shot, and researchers will check their immune response and any side effects one month later. The goal is to see if the booster is safe and effective for this age group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.